Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in December 2014 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Poseida Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Poseida Therapeutics Inc market cap is $925.41M.
What is the 52-week high for Poseida Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Poseida Therapeutics Inc 52 week high is $9.67 as of September 12, 2025.
What is the 52-week low for Poseida Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Poseida Therapeutics Inc 52 week low is $2.32 as of September 12, 2025.
What is Poseida Therapeutics Inc stock price today?
Poseida Therapeutics Inc stock price today is $9.50.
What was Poseida Therapeutics Inc stock price yesterday?
Poseida Therapeutics Inc stock price yesterday was $9.56.
What is the PE ratio of Poseida Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Poseida Therapeutics Inc’s P/E ratio is -15.00.
What is the Price-to-Book ratio of Poseida Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Poseida Therapeutics Inc P/B ratio is 10.6112.
What is the 50-day moving average of Poseida Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Poseida Therapeutics Inc 50-day moving average is $9.50.